11 November 2011, Lysaker, Norway: Primary insider, CEO in Pronova BioPharma ASA, Morten Jurs, has bought 10 000 shares in the company today.

The shares were bought at an average share price of NOK 5.7924 and are held by Jurs AS, which is owned 100 percent by Morten Jurs.

In addition, Mr Jurs has sold 40 000 shares owned personally to his own wholly owned company Jurs AS at NOK 5.7924 per share.

Total number of shares held by Mr Jurs after the purchase is 509 375 shares held by Jurs AS.